inQB8 Medical prosthetic heart valve patent granted
Summary
The USPTO granted patent US12594160B2 to inQB8 Medical Technologies, LLC for a prosthetic heart valve designed to improve functionality of native heart valves. The invention includes support structures with an elongate central passageway and leaflet elements for blood flow control, configured to biodynamically fix to native leaflets. The patent contains 24 claims and is classified under CPC A61F 2/2418.
What changed
The USPTO issued a patent grant for a prosthetic heart valve invention to inQB8 Medical Technologies, LLC. The patent covers exemplary prosthetic heart valves with one or more support structures defining an elongate central passageway and plural leaflet elements attached to control blood flow, configured to biodynamically fix to native heart valve leaflets.
For medical device manufacturers and healthcare companies developing cardiovascular products, this patent establishes intellectual property rights that may require licensing negotiations or design-around considerations. Competitors in the prosthetic heart valve space should conduct freedom-to-operate analyses and monitor the patent's claims when developing similar devices.
What to do next
- Monitor for potential licensing opportunities
- Review patent claims for competitive analysis
- Assess freedom-to-operate for related medical device development
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Prosthetic heart valve
Grant US12594160B2 Kind: B2 Apr 07, 2026
Assignee
inQB8 Medical Technologies, LLC
Inventors
J. Brent Ratz, Arshad Quadri, Christopher Stivers
Abstract
Described herein are prosthetic heart valves and methods for improving the functionality of native heart valves. An exemplary prosthetic heart valve may include one or more support structures, in which at least one support structure defines an elongate central passageway having a longitudinal. The prosthetic heart valve may include a plurality of leaflet elements attached to the at least one support structure and disposed within the elongate central passageway for control of blood flow through the elongate central passageway. The at least one support structure may be configured to biodynamically fix the prosthetic heart valve to native leaflets of a native heart valve of a heart.
CPC Classifications
A61F 2/2418
Filing Date
2021-08-27
Application No.
17458914
Claims
24
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.